Cardiovascular benefits of GLP-1 (liraglutide) treatment in experimental arterial hypertension are mediated by the endothelial GLP-1 receptor

Citation
Steven S, Helmstaedter J, Filippou K, et al. Eur Heart J 2019;40(Suppl 1):P4476.